Genistein: A phytoestrogen with multifaceted therapeutic properties

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 11, 2014, Pages 920-940

  Saha, Sukanya ^a   Sadhukhan, Pritam ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Anticancer; Antidiabetic; Cytotoxicity; Estrogen receptors; Oxidative stress; Pathophysiology; Phytoestrogens

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIMUTAGENIC AGENT; CYTOCHROME P450 2E1; ENDOTHELIN 1; ESTROGEN RECEPTOR; GELATINASE A; GENISTEIN; GLUCURONOSYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PHYTOESTROGEN; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SECRETED FRIZZLED RELATED PROTEIN 2; SOMATOMEDIN C; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR SOX7; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT5A PROTEIN;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CARCINOMA CELL LINE; CARDIOVASCULAR DISEASE; CELL CYCLE REGULATION; CELL PROLIFERATION ASSAY; CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); COLON CANCER; CYTOTOXICITY; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG METABOLISM; ENZYME INHIBITION; HEALTH HAZARD; HUMAN; IMMUNOMODULATION; INTRACELLULAR SIGNALING; KIDNEY DISEASE; LIVER PROTECTION; METABOLIC DISORDER; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

EID: 84911378473     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557514666141029233442     Document Type: Article

References (273)

1. Wolfrom, M.L.; Morgan, P.W.; Benton, F. Osage Orange Pigments. IV. Degree of Unsaturation and Flavone Nature. J. Am. Chem. Soc., 1940, 62(6), 1484-1489.
2. Perkin, A.G.; Newbury, F.G. The colouring matters contained in dyer's broom (Genista tinctoria) and heather (Calluna vulgaris). J. Chem. Soc. Trans., 1899, 75, 830-839.
3. Walter, E. Genistin (an isoflavone glucoside) and its aglucone, genistein, from soybeans. J. Am. Chem. Soc., 1941, 63(12), 3273-3276.
4. Polkowski, K.; Mazurek, A.P. Biological properties of genistein. A review of in vitro and in vivo data. Acta. Pol. Pharma., 2000, 57(2), 135-155.
5. Choi, C.; Cho, H.; Park, J.; Cho, C.; Song, Y. Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages. Biosci. Biotechnol. Biochem., 2003, 67(9), 1916-1922.
6. Ruetten, H.; Thiemermann, C. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br. J. Pharmacol., 1997, 122(1), 59-70.
7. Ososki, A.L.; Kennelly, E.J. Phytoestrogens: a review of the present state of research. Phytother. Res., 2003, 17(8), 845-869.
8. Cassidy, A.; Griffin, B. Phyto-oestrogens: a potential role in the prevention of CHD? P. Nutr. Soc., 1999, 58(1), 193-199.
9. Adlercreutz, H.; Markkanen, H.; Watanabe, S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 1993, 342(8881), 1209-1210.
10. Kaufman, P.B.; Duke, J.A.; Brielmann, H.; Boik, J.; Hoyt, J.E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J. Altern. Complement. Med., 1997, 3(1), 7-12.
11. Rietjens, I.M.; Sotoca, A.M.; Vervoort, J.; Louisse, J. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol. Nutr. Food Res., 2013, 57(1), 100-113.
12. Luo, K.; Zha, X.Q.; Luo, J.P. Structure kinetic model of Maackia amurensis cells in suspension culture. Chin. J. Biotechnol., 2007, 23(4), 657-661.
13. Luo, J.P.; Luo, K.; Chen, X.Y.; Jiang, S.T. Optimization for isoflavone production in Maackia amurensis suspension cells based on neural networks and accelerating genetic algorithm. Chin. J. Biotechnol., 2004, 20(5), 759-763.
14. Verdrengh, M.; Jonsson, I.M.; Holmdahl, R.; Tarkowski, A. Genistein as an anti-inflammatory agent. Inflamm. Res., 2003, 52(8), 341-346.
15. Vitale, D.C.; Piazza, C.; Melilli, B.; Drago, F.; Salomone, S. Isoflavones: estrogenic activity, biological effect and bioavailability. Eur. J. Drug. Metab. Pharmacokinet., 2013, 38(1), 15-25.
16. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 1987, 262(12), 5592-5595.
17. Messina, M.J.; Persky, V.; Setchell, K.D.; Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer., 1994, 21(2), 113-131.
18. Wei, H.; Bowen, R.; Cai, Q.; Barnes, S.; Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Bio. Med., 1995, 208(1), 124-130.
19. Adlercreutz, H. Phytoestrogens. State of the art. Environ. Toxicol. Pharmacol., 1999, 7(3), 201-207.
20. Behloul, N.; Wu, G. Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur. J. Pharmacol., 2013, 698, 31-38.
21. Adlercreutz, H.; Honjo, H.; Higashi, A.; Fotsis, T.; Hamalainen, E.; Hasegawa, T.; Okada, H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr., 1991, 54(6), 1093-1100.
22. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3(10), 768-780.
23. Kar, P.K.; Tandon, V.; Saha, N. Anthelmintic efficacy of genistein, the active principle of Flemingia vestita (Fabaceae): alterations in the free amino acid pool and ammonia levels in the fluke, Fasciolopsis buski. Parasitol. Int., 2004, 53(4), 287-291.
24. Paradkar, P.N.; Blum, P.S.; Berhow, M.A.; Baumann, H.; Kuo, S.M. Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine. Cancer lett., 2004, 215(1), 21-28.
25. McDowell, M.L.; Das, A.; Smith, J.A.; Varma, A.K.; Ray, S.K.; Banik, N.L. Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines. Neurochem. Int., 2011, 59(2), 175-184.
26. Potter, S.M.; Baum, J.A.; Teng, H.; Stillman, R.J.; Shay, N.F. Erdman, J.W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr., 1998, 68(6 Suppl), 1375s-1379s.
27. Raghu Nadhanan, R.; Skinner, J.; Chung, R.; Su, Y.W.; Howe, P.R.; Xian, C.J. Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats. PloS ONE, 2013, 8(8), e71592.
28. Donovan, S.M.; Andres, A.; Mathai, R.A.; Kuhlenschmidt, T.B.; Kuhlenschmidt, M.S. Soy formula and isoflavones and the developing intestine. Nutr. Rev., 2009, 67(Suppl 2), S192-200.
29. Kang, J.L.; Lee, H.W.; Lee, H.S.; Pack, I.S.; Chong, Y.; Castranova, V.; Koh, Y. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am. J. Respir. Crit. Care. Med., 2001, 164(12), 2206-2212.
30. Mahn, K.; Borras, C.; Knock, G.A.; Taylor, P; Khan, I.Y.; Sugden, D.; Poston, L.; Ward, J.P.; Sharpe, R.M.; Vina, J. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J., 2005, 19(12), 1755-1757.
31. Zhang, L.L.; Li, L.; Wu, D.P.; Fan, J.H.; Li, X.; Wu, K.J.; Wang, X.Y.; He, D.L. A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells. Acta. Pharmacol. Sin., 2008, 29(9), 1060-1068.
32. Wegrzyn, G.; Jakobkiewicz-Banecka, J.; Gabig-Ciminska, M; Piotrowska, E.; Narajczyk, M.; Kloska, A.; Malinowska, M.; Dziedzic, D.; Golebiewska, I.; Moskot, M. Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem. Soc. Trans., 2010, 38(2), 695-701.
33. Setchell, K.D.; Zimmer-Nechemias, L.; Cai, J.; Heubi, J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet, 1997, 350(9070), 23-27.
34. Rimbach, G.; De Pascual-Teresa, S.; Ewins, B.A.; Matsugo, S.; Uchida, Y.; Minihane, A.M.; Turner, R.; VafeiAdou, K.; Weinberg, P.D. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica, 2003, 33(9), 913-925.
35. Cho, S.; Shin, M.H.; Kim, Y.K.; Seo, J.E.; Lee, Y.M.; Park, C.H.; Chung, J.H. Effects of infrared radiation and heat on human skin aging in vivo. J. Invest. Dermatol., 2009, 14(1), 15-19.
36. Papazisis, K.T.; Kalemi, T.G.; Zambouli, D.; Geromichalos, G.D.; Lambropoulos, A.F.; Kotsis, A; Boutis, L.L.; Kortsaris, A.H. Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro. Cancer lett., 2006, 233(2), 255-264.
37. Yan, G.R.; Xiao, C.L.; He, G.W.; Yin, X.F.; Chen, N.P.; Cao, Y.; He, Q.Y. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics, 2010, 10(5), 976-986.
38. Sung, M.J.; Kim, D.H.; Jung, Y.J.; Kang, K.P.; Lee, A.S.; Lee, S.; Kim, W.; Davaatseren, M; Hwang, J.T.; Kim, H.J. Genistein protects the kidney from cisplatin-induced injury. Kidney Int., 2008, 74(12), 1538-1547.
39. Cooke, P.S.; Selvaraj, V.; Yellayi, S. Genistein, estrogen receptors, and the acquired immune response. J. Nutr., 2006, 136(3), 704-708.
40. Setchell, K.D.; Cassidy, A.; Detary isoflavones: biological effects and relevance to human health. J. Nutr., 1999, 129(3), 758s-767s.
41. Foti, P.; Erba, D.; Riso, P.; Spadafranca, A.; Criscuoli, F.; Testolin, G. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch. Biochem. Biophys., 2005, 433(2), 421-427.
42. Yu, O.; Jung, W.; Shi, J.; Croes, R.A.; Fader, G.M.; McGonigle, B.; Odell, J.T. Production of the isoflavones genistein and daidzein in non-legume dicot and monocot tissues. Plant Physiol., 2000, 124(2), 781-794.
43. Spector, L.G.; Xie, Y.; Robison, L.L.; Heerema, N.A.; Hilden, J.M.; Lange, B.; Felix, C.A.; Davies, S.M.; Slavin, J.; Potter, J.D. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol. Biomarkers Prevent., 2005, 14(3), 651-655.
44. Azarova, A.M.; Lin, R.K.; Tsai, Y.C.; Liu, L.F.; Lin, C.P.; Lyu, Y.L. Genistein induces topoisomerase IIbeta- and proteasomemediated DNA sequence rearrangements: Implications in infant leukemia. Biochem. Biophys. Res. Commun., 2010, 399(1), 66-71.
45. Ehrlich, P.R.; Raven, P.H. Butterflies and plants: a study in coevolution. Evolution, 1964, 18(4), 586-608.
46. Dixon, R.A.; Ferreira, D. Genistein. Phytochemistry, 2002, 60(3), 205-211.
47. Pandit, N.T.; Patravale, V.B. Design and optimization of a novel method for extraction of genistein. Indian J. Pharm. Sci., 2011, 73(2), 184-192.
48. Wang, C.C.; Prasain, J.K.; Barnes, S. Review of the methods used in the determination of phytoestrogens. J Chromatogr. B., 2002, 777(1-2), 3-28.
49. Barnes, S.; Kim, H.; Darley-Usmar, V; Patel, R; Xu, J.; Boersma, B.; Luo, M. Beyond ERalpha and ERbeta: estrogen receptor binding is only part of the isoflavone story. J. Nutr., 2000, 130(3), 656s-667s.
50. McDonnell, D.P.; Clemm, D.L.; Hermann, T.; Goldman, M.E.; Pike, J.W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol., 1995, 9(6), 659-669.
51. Barkhem, T.; Carlsson, B.; Nilsson, Y.; Enmark, E.; Gustafsson, J.; Nilsson, S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol., 1998, 54(1), 105-112.
52. Wang, T.T.; Sathyamoorthy, N.; Phang, J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 1996, 17(2), 271-275.
53. Guo, Q.; Rimbach, G.; Moini, H.; Weber, S.; Packer, L. ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology, 2002, 179(1), 171-180.
54. Fuchs D.; Erhard, P.; Rimbach, G.; Daniel, H.; Wenzel, U. Genistein blocks homocysteine_induced alterations in the proteome of human endothelial cells. Proteomics, 2005, 5(11), 2808-2818.
55. Liu, Y.; Hu, M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug. Metab. Dispos., 2002, 30(4), 370-377.
56. Matthies, A.; Loh, G.; Blaut, M.; Braune, A. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr., 2012, 142(1), 40-46.
57. Squadrito, F.; Bitto, A. In:Isoflavones: Chemistry, Analysis, Function and Effects; Victor R. Preedy, Ed. RSC Publishing: Cambridge, 2013; pp. 148-156.
58. Cabiscol, E.; Piulats, E.; Echave, P.; Herrero, E.; Ros, J. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J. Biol. Chem., 2000, 275(35), 27393-27398.
59. Bilinski, T.; Litwinska, J.; Blaszczynski, M.; Bajus, A. Superoxide dismutase deficiency and the toxicity of the products of autooxidation of polyunsaturated fatty acids in yeast. Biochim. Biophys. Acta, 1989, 1001(1), 102-106.
60. Yakes, F.M.; Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A., 1997, 94(2), 514-519.
61. Das, J; Ghosh, J; Manna, P; Sil, PC. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem. Pharmacol., 2011, 81(7), 891-909.
62. Das, J.; Ghosh, J.; Manna, P.; Sil, P.C. Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis. Amino Acids, 2012, 42(5), 1839-1855.
63. Das, J.; Ghosh, J.; Roy, A.; Sil, P.C. Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFkappaB pathways. Toxicol. Appl. Pharmacol., 2012, 260(1), 35-47.
64. Das, J.; Roy, A.; Sil, P.C. Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review. Food Funct., 2012, 3(12), 1251-1264.
65. Pal, P.B.; Pal, S.; Das, J.; Sil, P.C. Modulation of mercury-induced mitochondria-dependent apoptosis by glycine in hepatocytes. Amino Acids, 2012, 42(5), 1669-1683.
66. Ghosh, J.; Das, J.; Manna, P.; Sil, P.C. Acetaminophen induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid. Toxicology, 2010, 268(1-2), 8-18.
67. Ghosh, J.; Das, J.; Manna, P.; Sil, P.C. Hepatotoxicity of di-(2- ethylhexyl)phthalate is attributed to calcium aggravation, ROSmediated mitochondrial depolarization, and ERK/NF-kappaB pathway activation. Free Radic. Biol. Med., 2010, 49(11), 1779-1791.
68. Ghosh, J.; Das, J.; Manna, P.; Sil, P.C. Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection. Free Radic. Biol. Med., 2010, 48(4), 535-553.
69. Ghosh, J.; Das, J.; Manna, P.; Sil, P.C. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials, 2011, 32(21), 4857-4866.
70. Ghosh, M.; Manna, P.; Sil, P.C. Protective role of a coumarinderived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs, NF-kappaB and mitochondria-dependent pathways. Free. Radic. Res., 2011, 45(5), 620-637.
71. Bhattacharyya, S.; Ghosh, J.; Sil, P.C. Iron induces hepatocytes death via MAPK activation and mitochondria-dependent apoptotic pathway: beneficial role of glycine. Free. Radic. Res., 2012, 46(10), 1296-1307.
72. Pal, S.; Pal, P.B.; Das, J.; Sil, P.C. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology, 2011, 283(2- 3), 129-139.
73. Pal, P.B.; Sinha, K.; Sil, P.C. Mangiferin, a natural xanthone, protects murine liver in Pb(II) induced hepatic damage and cell death via MAP kinase, NF-kappaB and mitochondria dependent pathways. PLoS ONE, 2013, 8(2), e56894.
74. Das, J.; Ghosh, J.; Manna, P.; Sinha, M.; Sil, P.C. Arsenic-induced oxidative cerebral disorders: protection by taurine. Drug Chem. Toxicol., 2009, 32(2), 93-102.
75. Das, J.; Ghosh, J.; Manna, P.; Sinha, M.; Sil, P.C. Taurine protects rat testes against NaAsO(2)-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways. Toxicol. Lett., 2009, 187(3), 201-210.
76. Manna, P.; Sinha, M.; Sil, P.C. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology, 2009, 257(1-2), 53-63.
77. Manna, P.; Sinha, M.; Sil, P.C. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades. Chem. Biol. Interact., 2009, 181(3), 297-308.
78. Manna, P.; Das, J.; Ghosh, J.; Sil, P.C. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Free Radic. Biol. Med., 2010, 48(11), 1465-1484.
79. Bhattacharya, S.; Manna, P.; Gachhui, R.; Sil, P.C. D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-kappaB and PKC signaling. Toxicol. Appl. Pharmacol., 2013, 267(1), 16-29.
80. Bhattacharya, S.; Gachhui, R.; Sil, P.C. The prophylactic role of Dsaccharic acid-1,4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diabetic rats. Food Funct., 2013, 4(2), 283-296.
81. Das, J.; Sil, P.C. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids, 2012, 43(4), 1509-1523.
82. Sarkar, M.K.; Sil, P.C. Prevention of tertiary butyl hydroperoxide induced oxidative impairment and cell death by a novel antioxidant protein molecule isolated from the herb, Phyllanthus niruri. Toxicol. In Vitro, 2010, 24(6), 1711-1719.
83. Ghosh, M.; Das, J.; Sil, P.C. D(+) galactosamine induced oxidative and nitrosative stress-mediated renal damage in rats via NF-kappaB and inducible nitric oxide synthase (iNOS) pathways is ameliorated by a polyphenol xanthone, mangiferin. Free Radic. Res., 2012, 46(2), 116-132.
84. Sinha, K.; Das, J.; Pal, P.B.; Sil, P.C. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch. Toxicol., 2013, 87(7), 1157-1180.
85. Borras, C.; Gambini, J.; Lopez-Grueso, R.; Pallardo, F.V.; Vina J. Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim. Biophys. Acta, 2010, 1802(1), 205-211.
86. Han, R.M.; Tian, Y.X.; Liu, Y.; Chen, C.H.; Ai, X.C.; Zhang, J.P.; Skibsted, L.H. Comparison of flavonoids and isoflavonoids as antioxidants. J. Agricult. Food Chem., 2009, 57(9), 3780-3785.
87. Das, J.; Vasan, V.; Sil, P.C. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol. Appl. Pharmacol., 2012, 258(2), 296-308.
88. Rashid, K.; Bhattacharya, S.; Sil, P.C. Protective role of Dsaccharic acid-1,4-lactone in alloxan induced oxidative stress in the spleen tissue of diabetic rats is mediated by suppressing mitochondria dependent apoptotic pathway. Free Radic. Res., 2012, 46(3), 240-252.
89. Rashid, K.; Das, J.; Sil, P.C. Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats. Food Chem. Toxicol., 2013, 51, 317-329.
90. Fatehi-Hassanabad, Z.; Chan, C.B.; Furman, B.L. Reactive oxygen species and endothelial function in diabetes. Eur. J. Pharmacol., 2010, 636(1-3), 8-17.
91. Grattagliano, I.; Palmieri, V.O.; Portincasa, P.; Moschetta, A.; Palasciano, G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J. Nutr. Biochem., 2008, 19(8), 491-504.
92. Rains, J.L.; Jain, S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med., 2011, 50(5), 567-575.
93. Schonfeld, P.; Wojtczak, L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med., 2008, 45(3), 231-241.
94. Behl, C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol., 1999, 57(3), 301-323.
95. Hirsch, E.C. Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol., 1993, 33(Suppl 1), 52-59.
96. Andrus, P.K.; Fleck, T.J.; Gurney, M.E.; Hall, E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 1998, 71(5), 2041-2048.
97. Ames, B.N.; Gold, L.S.; Willett, W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. U.S.A., 1995, 92(12), 5258-5265.
98. Farrugia, G.; Balzan, R. Oxidative stress and programmed cell death in yeast. Front. Oncol., 2012, 2(64), 1-21.
99. Orr, W.C.; Sohal, R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science, 1994, 263(5150), 1128-1130.
100. Pierce, G.B.; Parchment, R.E.; Lewellyn, A.L. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation, 1991, 46(3),181-186.
101. Shaterzadeh, H.; Burger-Mendonca, M.; Alonso, A.; Hermes-Lima, M. The antioxidant effect of genistein on the in vitro metalmediated formation of free radicals. Clin. Biochem., 2011, 44(13), S226.
102. Elmarakby, A.A.; Ibrahim, A.S.; Faulkner, J.; Mozaffari, M.S.; Liou, G.I.; Abdelsayed, R. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul. Pharmacol., 2011, 55(5),149-156.
103. Kairane, C.; Mahlapuu, R.; Ehrlich, K.; Zilmer, M.; Soomets, U. The effects of different antioxidants on the activity of cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer's disease and age-matched normal brains. Curr. Alzheimer Res., 2014, 11(1), 79-85.
104. Evsen, M.S.; Ozler, A.; Gocmez, C.; Varol, S.; Tunc, S.Y.; Akil, E.; Uzar, E.; Kaplan, I. Effects of estrogen, estrogen/progesteron combination and genistein treatments on oxidant/antioxidant status in the brain of ovariectomized rats. Eur. Rev. Med. Pharmacol. Sci., 2013, 17(14), 1869-1873.
105. Ma, W.; Yuan, L.; Yu, H.; Ding, B.; Xi, Y.; Feng, J.; Xiao, R. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells. Int. J. Dev. Neurosci., 2010, 28(4), 289-295.
106. Hsieh, H.M.; Wu, W.M.; Hu, M.L. Genistein attenuates Dgalactose- induced oxidative damage through decreased reactive oxygen species and NF-kappaB binding activity in neuronal PC12 cells. Life Sci., 2011, 88(1-2), 82-88.
107. Valsecchi, A.E.; Franchi, S.; Panerai, A.E.; Rossi, A.; Sacerdote, P.; Colleoni, M. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur. J. Pharmacol., 2011, 650(2-3), 694-702.
108. Ma, W.W.; Hou, C.C.; Zhou, X.; Yu, H.L.; Xi, Y.D.; Ding, J.; Zhao, X.; Xiao, R. Genistein alleviates the mitochondria-targeted DNA damage induced by beta-amyloid peptides 25-35 in C6 glioma cells. Neurochem. Res., 2013, 38(7), 1315-1323.
109. Wang, R.; Tu, J.; Zhang, Q.; Zhang, X.; Zhu, Y.; Ma, W.; Cheng, C; Brann, D.W.; Yang, F. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO_1 signaling. Hippocampus, 2013, 23(7), 634-647.
110. Squadrito, F.; Altavilla, D.; Morabito, N.; Crisafulli, A.; D'Anna, R.; Corrado, F.; Ruggeri, P.; Campo, G.M.; Calapai, G.; Caputi, A.P. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis, 2002, 163(2), 339-347.
111. Kim, M.J.; Lim, Y. Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage. Mediators Inflamm, 2013, 2013:510212.
112. Palanisamy, N.; Viswanathan, P.; Anuradha, C.V. Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Ren. Fail., 2008, 30(6), 645-654.
113. Choi, J.S.; Song, J. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition, 2009, 25(6), 676-685.
114. Fan, Y.J.; Rong, Y.; Li, P.F.; Dong, W.L.; Zhang, D.Y.; Zhang, L.; Cui, M.J. Genistein protection against acetaminophen-induced liver injury via its potential impact on the activation of UDPglucuronosyltransferase and antioxidant enzymes. Food Chem. Toxicol., 2013, 55, 172-181.
115. Huang, Q.; Huang, R.; Zhang, S.; Lin, J.; Wei, L.; He, M., Zhuo L.; Lin, X. Protective effect of genistein isolated from Hydrocotyle sibthorpioides on hepatic injury and fibrosis induced by chronic alcohol in rats. Toxicol. Lett., 2013, 217(2), 102-110.
116. Lin, X.; Zhang, S.; Huang, R.; Wei, L.; Liang, C.; Chen, Y.; Lv, S.; Liang, S.; Wu, X.; Huang, Q. Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice. Biol. Pharm. Bull., 2014, 37(4), 625-632.
117. Georgetti, S.R., Casagrande, R.; Vicentini, F.T.; Baracat, M.M.; Verri, W.A.; Fonseca, M.J. Protective effect of fermented soybean dried extracts against tpa-induced oxidative stress in hairless mice skin. Bio. Med. Res. Int., 2013; 2013:340626.
118. Jurzak, M.; Adamczyk, K. Influence of genistein on c-jun, c-fos and fos-b of ap-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro. Acta Pol. Pharm., 2013, 70(2), 205-213.
119. Anderson, J.J.; Ambrose, W.W.; Garner, S.C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med., 1998, 217(3), 345-350.
120. Pandey, A.; Misra, P.; Khan, M.P.; Swarnkar, G.; Tewari, M.C.; Bhambhani, S.; Trivedi, R.; Chattopadhyay, N.; Trivedi, P.K. Co_expression of Arabidopsis transcription factor, AtMYB12, and soybean isoflavone synthase, GmIFS1, genes in tobacco leads to enhanced biosynthesis of isoflavones and flavonols resulting in osteoprotective activity. Plant Biotech. J., 2014, 12(1), 69-80.
121. Teixeira, C.; Simoes, R.; Santos, M.; Calio, M.; Soares Jr, J.; Simoes, M.; Bertoncini, C.; Higa, E.; Carbonel, A. Soybean concentrated extract counteracts oxidative stress in the uterus of rats. Climacteric, 2014, 17(4), 402-409.
122. Vanhees, K.; van Schooten, F.J.; van Waalwijk, van Doorn-Khosrovani, S.B.; van Helden, S.; Munnia, A.; Peluso, M.; Briede, J.J.; Haenen, G.R.; Godschalk, R.W. Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage. Free Radic. Biol. Med., 2013, 57, 154-161.
123. Reddy, L.; Odhav, B.; Bhoola, K. Natural products for cancer prevention: a global perspective. Pharmacol. Ther., 2003, 99(1), 1-13.
124. Handelman, GJ. The evolving role of carotenoids in human biochemistry. Nutrition, 2001, 17(10), 818-822.
125. Dong, Y.; Yang, MM-P.; Kwan, C-Y. In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs. Life Sci., 1997, 60(8), PL135-PL140.
126. Dhandayuthapani, S.; Marimuthu, P.; Hormann, V.; Kumi-Diaka, J.; Rathinavelu, A. Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein. J. Med. Food, 2013, 16(2), 139-146.
127. Wei, H.; Bowen, R.; Cai, Q.; Barnes, S.; Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Exp. Biol. Med., 1995, 208(1), 124-130.
128. Davis, J.N.; Kucuk, O.; Sarkar, F.H. Expression of prostate_specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol. Carcinog., 2002, 34(2), 91-101.
129. Lamartiniere, C.A.; Moore, J.B.; Brown, N.M.; Thompson, R.; Hardin, M.J.; Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis, 1995, 16(11), 2833-2840.
130. Li, Y.; Meeran, S.M.; Patel, S.N.; Chen, H.; Hardy, T.M.; Tollefsbol, T.O. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα- negative breast cancer. Mol. Cancer, 2013, 12(9).2
131. Nakamura, A.; Aizawa, J.; Sakayama, K.; Kidani, T.; Takata, T.; Norimatsu, Y.; Miura, H.; Masuno, H. Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8. BMC Cell Biol., 2012, 13(1), 24.
132. Banerjee, S.; Zhang, Y.; Ali, S.; Bhuiyan, M.; Wang, Z.; Chiao, P.J.; Philip, P.A.; Abbruzzese, J.; Sarkar, F.H. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res., 2005, 65(19), 9064-9072.
133. Bhamre, S.; Sahoo, D.; Tibshirani, R.; Dill, D.L.; Brooks, J.D. Gene expression changes induced by genistein in the prostate cancer cell line LNCaP. Open Prost. Cancer J., 2010, 3, 86-98.
134. Pavese, J.M.; Farmer, R.L.; Bergan, R.C. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev., 2010, 29(3), 465-482.
135. Ravindranath, M.H.; Muthugounder, S.; Presser, N.; Viswanathan, S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv. Exp. Med. Biol., 2004, 546, 121-165.
136. Adjakly, M.; Ngollo, M.; Boiteux, J-P.; Bignon, Y-J.; Guy, L.; Bernard-Gallon, D. Genistein and daidzein: different molecular effects on prostate cancer. Anticancer Res., 2013, 33(1), 39-44.
137. Nadal-Serrano, M.; Pons, D.G.; Sastre-Serra, J.; Blanquer-Rossello, M.; Roca, P.; Oliver, J. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: Effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell Biol., 2013, 45(9), 2045-2051.
138. Watts, P.J.; Lllum, L. Colonic drug delivery. Drug Dev. Ind. Pharm., 1997, 23(9), 893-913.
139. Midgley, R.S.; Al_Salama, H.M.; Merrie, A.; Mortensen, N.; Kerr, D.J. Textbook of Clinical Gastroenterology and Hepatology. 2nd ed.; Wiley-Blackwell, Oxford: UK, 2005.
140. Messina, M.; Bennink, M. 10 Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Bailliere Clin. Endoc., 1998, 12(4), 707-728.
141. Qi, W.; Weber, CR.; Wasland, K.; Roy, H.; Wali, R.; Joshi, S.; Savkovic, S.D. Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2011, 300(2), G264-G272.
142. Kim, E.J.; Shin, H-K.; Park, J.H.Y. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein. J. Med. Food., 2005, 8(4), 431-438.
143. Adhami, V.M.; Afaq, F.; Mukhtar, H. Insulin-like growth factor-I axis as a pathway for cancer chemoprevention. Clin. Cancer Res., 2006, 12(19), 5611-5614.
144. Zhang, Y.; Li, Q.; Zhou, D.; Chen, H. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats. Br. J. Nutr., 2013, 109(1), 33-42.
145. Zhang, Y.; Li, Q.; Chen, H. DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development. Carcinogenesis, 2013, 34(8), 1756-1763.
146. Fan, Y.; Li, G.; Wang, Y.; Ren, Q.; Shi, H. Effects of genistein on colon cancer cells in vitro and in vivo and its mechanism of action. Zhonghua Zhong Liu Za Zhi, 2010, 32(1), 4-9.
147. Linsalata, M.; Russo, F.; Notarnicola, M.; Guerra, V.; Cavallini, A.; Clemente, C.; Messa, C. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr. Cancer 2005, 52(1), 84-93.
148. Han, J.; Kurita, Y.; Isoda, H. Genistein-induced G2/M cell cycle arrest of human intestinal colon cancer Caco-2 cells is associated with Cyclin B1 and Chk2 down-regulation. Cytotechnology, 2013, 65(6), 973-978.
149. Chen, D.; Li, Q.; Chen, H. Genistein-induced histone modifications on ATF3 may contribute to cell cycle arrest and apoptosis in human colon cancer cell line SW620 (800.8). FASEB J. 2014, 28(Suppl 1), 800-808.
150. Salti, G.; Grewal, S.; Mehta, R.; Das Gupta, T.; Boddie Jr, A.; Constantinou, A. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur. J.Cancer, 2000, 36(6), 796-802.
151. Zhang, Z.; Wang, C-Z.; Du, G-J.; Qi, L-W.; Calway, T.; He, T-C.; Du, W.; Yuan, C-S. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int. J. Oncol. 2013, 43(1), 289-296.
152. Mizushina, Y.; Shiomi, K.; Kuriyama, I.; Takahashi, Y.; Yoshida, H. Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation. Int. J. Oncol., 2013, 43(4), 1117-1124.
153. Chung, E.; Gillman, M. Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy. Med. J. Aust., 2014, 200(10), 582.
154. Shen, MM.; Abate-Shen, C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev., 2010, 24(18), 1967-2000.
155. Zhang, L.; Li, L.; Li, X. A novel anti_cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells1. Acta Pharmacol. Sin., 2008, 29(9), 1060-1068.
156. Pavese, J.M.; Krishna, S.N.; Bergan, R.C. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am. J. Clin. Nutr., 2014, 100(Sup 1), 431S-436S.
157. Mahmoud, A.M.; Yang, W.; Bosland, M.C. Soy isoflavones and prostate cancer: A review of molecular mechanisms. J. Steroid Biochem. Mol. Biol., 2014, 140, 116-132.
158. Fang, M.Z.; Chen, D.; Sun, Y.; Jin, Z.; Christman, J.K.; Yang, C.S. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res., 2005, 11(19 Pt 1), 7033-7041.
159. Majid, S.; Dar, A.A.; Shahryari, V.; Hirata, H.; Ahmad, A.; Saini, S.; Tanaka, Y.; Dahiya, A.V.; Dahiya, R. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer, 2010, 116(1), 66-76.
160. Phillip, C.J.; Giardina, C.K.; Bilir, B.; Cutler, D.J.; Lai, Y.H.; Kucuk, O.; Moreno, C.S. Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells. BMC Cancer, 2012, 12, 145.
161. Li, Y.; Kucuk, O.; Hussain, M.; Abrams, J.; Cher, M.L.; Sarkar, F.H. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/ receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res., 2006, 66(9), 4816-4825.
162. Phillip, C.J.; Giardina, C.K.; Bilir, B.; Cutler, D.J.; Lai, Y.H.; Kucuk, O.; Moreno, C.S. Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells. BMC Cancer, 2012, 12(1), 145.
163. Kumi-Diaka, J.; Merchant, K.; Haces, A.; Hormann, V.; Johnson, M. Genistein-selenium combination induces growth arrest in prostate cancer cells. J. Med. Food, 2010, 13(4), 842-850.
164. Shahi, P.; Seethammagari, M.R.; Valdez, J.M.; Xin, L.; Spencer, D.M. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation. Stem Cells, 2011, 29(4), 678-688.
165. Guo, L.; Zhong, D.; Lau, S.; Liu, X.; Dong, X.Y.; Sun, X.; Yang, V.W.; Vertino, P.M.; Moreno, C.S.; Varma, V.; and others. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol. Cancer Res., 2008, 6(9), 1421-1430.
166. Yee, D.S.; Tang, Y.; Li, X.; Liu, Z.; Guo, Y.; Ghaffar, S.; McQueen, P.; Atreya, D.; Xie, J.; Simoneau, A.R.; and others. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol. Cancer, 2010, 9, 162.
167. Mori, M.; Triboulet, R.; Mohseni, M.; Schlegelmilch, K.; Shrestha, K.; Camargo, F.D.; Gregory, R.I. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell, 2014, 156(5), 893-906.
168. Chiyomaru, T.; Yamamura, S.; Fukuhara, S.; Hidaka, H.; Majid, S.; Saini, S.; Arora, S.; Deng, G.; Shahryari, V.; Chang, I. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS ONE, 2013, 8(3), e58929.
169. Hirata, H.; Hinoda, Y.; Shahryari, V.; Deng, G.; Tanaka, Y.; Tabatabai, Z.; Dahiya, R. Genistein downregulates onco-miR- 1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells. Br. J. Cancer, 2014.
170. Ross, S.A.; Davis, C.D. MicroRNA, nutrition, and cancer prevention. Adv. Nutr., 2011, 2(6), 472-485.
171. Chiyomaru, T.; Yamamura, S.; Zaman, M.S.; Majid, S.; Deng, G.; Shahryari, V.; Saini, S.; Hirata, H.; Ueno, K.; Chang, I. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS ONE, 2012, 7(8), e43812.
172. Chen, Y.; Zaman, M.S.; Deng, G.; Majid, S.; Saini, S.; Liu, J.; Tanaka, Y.; Dahiya, R. MicroRNAs 221/222 and genisteinmediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res., 2011, 4(1), 76-86.
173. Nambiar, D.; Singh, R.P. Advances in prostate cancer chemoprevention: a translational perspective. Nutr. Cancer, 2013, 65(sup1), 12-25.
174. Bouker, K.B.; Hilakivi-Clarke, L. Genistein: does it prevent or promote breast cancer? Environ. Health Perspect., 2000, 108(8), 701-708.
175. Tsuboy, M.S.; Marcarini, J.C.; de Souza, A.O.; de Paula, N.A.; Dorta, D.J.; Mantovani, M.S.; Ribeiro L.R. Genistein at Maximal Physiologic Serum Levels Induces G0/G1 Arrest in MCF-7 and HB4a Cells, But Not Apoptosis. J. Med. Food, 2014.; 17(2), 218-225.
176. Hu, X-J.; Xie, M-Y.; Kluxen, F.M.; Diel, P. Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells. Arch. Toxicol., 2014, 88(3), 625-635.
177. Fan, P.; Fan, S.; Wang, H.; Mao, J.; Shi, Y.; Ibrahim, M.M.; Ma, W.; Yu, X.; Hou, Z.; Wang, B. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. J. Stem Cell Res. Ther., 2013, 4(6), 146.
178. McCarty, M.F. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypotheses, 2006, 66(6), 1093-1114.
179. Nadal-Serrano, M.; Pons, D.G.; Sastre-Serra, J.; Blanquer-Rossello Mdel, M.; Roca, P.; Oliver, J. Genistein modulates oxidative stress in breast cancer cell lines according to ERalpha/ERbeta ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell Biol., 2013, 45(9), 2045-2051.
180. Hwang, K.A.; Park, M.A.; Kang, N.H.; Yi, B.R.; Hyun, S.H.; Jeung, E.B.; Choi, K.C. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 beta-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways. Toxicol. Appl. Pharmacol., 2013, 272(3), 637-646.
181. Yan, G.R.; Zou, F.Y.; Dang, B.L.; Zhang, Y.; Yu, G.; Liu, X.; He, Q.Y. Genistein_induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study. Proteomics, 2012, 12(14), 2391-2399.
182. Limer, J.L.; Speirs, V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res., 2004, 6(3), 119-132.
183. Tsuchiya, H.; Nagayama, M.; Tanaka, T.; Furusawa, M.; Kashimata, M.; Takeuchi, H. Membrane-rigidifying effects of anticancer dietary factors. Biofactors, 2002, 16(3), 45-56.
184. Arunkumar, E.; Karthik, D.; Anuradha, C.V. Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat-highfructose diet-fed mice. Pharm. Biol., 2013, 51(7), 815-824.
185. Arunkumar, E.; Anuradha, C.V. Genistein promotes insulin action through adenosine monophosphate–activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet. Nutr. Res., 2012, 32(8), 617-625.
186. Haneishi, A.; Takagi, K.; Asano, K.; Yamamoto, T.; Tanaka, T.; Nakamura, S.; Noguchi, T.; Yamada, K. Analysis of regulatory mechanisms of an insulin-inducible SHARP-2 gene by (S)-Equol. Arch. Biochem. Biophys., 2012, 525(1), 32-39.
187. Haneishi, A.; Takagi, K.; Asano, K.; Nakamura, S.; Kagawa, N.; Yamada, K. Genistein stimulates the insulin-dependent signaling pathway. Front. Biosci., 2011, 3, 1534-1540.
188. Salas, M.; Obando, P.; Ojeda, L.; Ojeda, P.; Perez, A.; Vargas- Uribe, M.; Rivas, CI.; Vera, J.C.; Reyes, A.M. Resolution of the direct interaction with and inhibition of the human GLUT1 hexose transporter by resveratrol from its effect on glucose accumulation. Am. J. Physiol.-Cell Ph., 2013, 305(1), C90-C99.
189. Fu, Z.; Gilbert, E.R.; Pfeiffer, L.; Zhang, Y.; Fu, Y.; Liu, D. Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Appl. Physiol. Nutr. Metab., 2012, 37(3), 480-488.
190. Kim, E-K.; Kwon, K-B.; Song, M-Y.; Seo, S-W.; Park, S-J.; Ka, SO.; Na, L.; Kim, K-A.; Ryu, D-G.; So, H-S. Genistein protects pancreatic β cells against cytokine-mediated toxicity. Mol. Cell. Endocrinol., 2007, 278(1), 18-28.
191. Liu, R.; Hu, Y.; Li, J.; Lin, Z. Production of soybean isoflavone genistein in non-legume plants via genetically modified secondary metabolism pathway. Metab. Eng., 2007, 9(1), 1-7.
192. Yang, W.; Wang, S.; Li, L.; Liang, Z.; Wang, L. Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage. Pancreas, 2011, 40(3), 396-402.
193. Fu, Z.; Zhang, W.; Zhen, W.; Lum, H.; Nadler, J.; Bassaganya- Riera, J.; Jia, Z.; Wang, Y.; Misra, H.; Liu, D. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology, 2010, 151(7), 3026-3037.
194. Fu, Z.; Liu, D. Long-term exposure to genistein improves insulin secretory function of pancreatic β-cells. Eur. J. Pharmacol., 2009, 616(1), 321-327.
195. Cheguru, P.; Chapalamadugu, K.C.; Doumit, M.E.; Murdoch, G.K.; Hill, R.A. Adipocyte differentiation-specific gene transcriptional response to C18 unsaturated fatty acids plus insulin. Pflugers Arch. Eur. J. Pharmacol., 2012, 463(3), 429-447.
196. Behloul, N.; Wu, G. Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur. J. Pharmacol., 2013, 698(1), 31-38.
197. Nazari, H.; Khaleghian, A.; Takahashi, A.; Harada, N.; Webster, N.; Nakano, M.; Kishi, K.; Ebina, Y.; Nakaya, Y. Cortactin, an actin binding protein, regulates GLUT4 translocation via actin filament remodeling. Biochem. (Mosc.), 2011, 76(11),1262-1269.
198. Nagaraju, G.P.; Zafar, S.F.; El Rayes, B.F. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr. Rev., 2013, 71(8), 562-572.
199. Ascencio, C.; Torres, N.; Isoard-Acosta, F.; Gomez-Perez, F.J.; Hernandez-Pando, R.; Tovar, A.R. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J. Nutr., 2004, 134(3), 522-529.
200. Szkudelska, K.; Nogowski, L. Genistein-a dietary compound inducing hormonal and metabolic changes. J. Steroid Biochem. Mol. Biol, 2007, 105(1), 37-45.
201. Mohamed Salih, S.; Nallasamy, P.; Muniyandi, P.; Periyasami, V.; Carani Venkatraman, A. Genistein improves liver function and attenuates non_alcoholic fatty liver disease in a rat model of insulin resistance. Diabetes, 2009, 1(4), 278-287.
202. Rauter, A.P.; Martins, A.; Borges, C.; Mota_Filipe, H.; Pinto, R.; Sepodes, B.; Justino, J. Antihyperglycaemic and protective effects of flavonoids on streptozotocin–induced diabetic rats. Phytother. Res., 2010, 24(S2), S133-S138.
203. Liao, W.; Jin, G.; Zhao, M.; Yang, H. The effect of genistein on the content and activity of alpha- and beta-secretase and protein kinase C in Abeta-injured hippocampal neurons. Basic Clin. Pharmacol. Toxicol., 2013, 112(3), 182-185.
204. Pan, M.; Han, H.; Zhong, C.; Geng, Q. Effects of genistein and daidzein on hippocampus neuronal cell proliferation and BDNF expression in H19-7 neural cell line. J. Nutr. Health Aging, 2012, 16(4), 389-394.
205. Yao, J.; Zhao, L.; Mao, Z.; Chen, S.; Wong, K.C.; To, J.; Brinton, R.D. Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Brain Res., 2013, 1514, 128-141.
206. Qiang, Q.; Adachi, H.; Huang, Z.; Jiang, Y.M.; Katsuno, M.; Minamiyama, M.; Matsumoto, S.; Kondo, N.; Miyazaki, Y.; Iida, M. Genistein, a natural product derived from soybeans, ameliorates polyglutamine_mediated motor neuron disease. J. Neurochem., 2013, 126(1), 122-130.
207. Suresh, P.; Raju, A.B. Antidopaminergic effects of leucine and genistein on shizophrenic rat models. Neurosciences (Riyadh), 2013, 18(3), 235-241.
208. Shi, R.; Wang, S.; Qi, X.; Chen, S.; Chen, P.; Zhang, Q. Lose dose genistein inhibits glucocorticoid receptor and ischemic brain injury in female rats. Neurochem. Int., 2014, 65, 14-22.
209. Adams, S.M.; Aksenova, M.V.; Aksenov, M.Y.; Mactutus, C.F.; Booze, R.M. Soy isoflavones genistein and daidzein exert antiapoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat1–86 exposure. PLoS ONE, 2012, 7(5), e37540. J. Pharmacol. Sci., 2014, 124(2), 123-128.
210. Yanagihara N, Zhang H, Toyohira Y, Takahashi K, Ueno S, Tsutsui M, Takahashi K. New Insights Into the Pharmacological Potential of Plant Flavonoids in the Catecholamine System. J. Pharmacol. Sci., 2014, 124(2), 123-128.
211. Xu, S.L.; Bi, C.W.; Choi, R.C.; Zhu, K.Y.; Miernisha, A.; Dong, T.T.; Tsim, K.W. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid. Based Complement. Alternat. Med., 2013, 2013, 127075.
212. Zhu, Y.; Dua, S.; Gold, M.S. Inflammation-induced shift in spinal GABAA signaling is associated with a tyrosine kinase-dependent increase in GABAA current density in nociceptive afferents. J. Neurophysiol., 2012, 108(9), 2581-2593.
213. Zhang, C.; Bosch, M.A.; Ronnekleiv, O.K.; Kelly, M.J. Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation. J. Endocrinol., 2013, 154(8), 2772-2783.
214. Westmark, C.J.; Westmark, P.R.; Malter, J.S. Soy-based diet exacerbates seizures in mouse models of neurological disease. J. Alzheimers Dis., 2013, 33(3), 797-805.
215. Verdrengh, M.; Jonsson, I.; Holmdahl, R.; Tarkowski, A. Genistein as an anti-inflammatory agent. Inflamm. Res., 2003, 52(8), 341-346.
216. Kim, Y.K.; Jang, Y.Y.; Kim, D.H.; Ko, H.H.; Han, E.S.; Lee, C.S. Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages. Biochem. Pharmacol., 2001, 61(1), 87-96.
217. Naucler, C.; Grinstein, S.; Sundler, R.; Tapper, H. Signaling to localized degranulation in neutrophils adherent to immune complexes. Leukoc. Biol., 2002, 71(4), 701-710.
218. McGregor, P.E.; Agrawal, D.K.; Edwards, J.D. Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun., 1994, 198(1), 359-365.
219. Weber, C.; Negrescu, E.; Erl, W.; Pietsch, A.; Frankenberger, M.; Ziegler-Heitbrock, H.; Siess, W.; Weber, P.C. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J. Immunol., 1995, 155(1), 445-451.
220. Knowles, R.G.; Moncada, S. Nitric oxide synthases in mammals. Biochem. J., 1994, 298(Pt 2), 249.
221. Alderton, W.; Cooper, C.; Knowles, R. Nitric oxide synthases: structure, function and inhibition. Biochem. J., 2001, 357, 593-615.
222. Korhonen, R.; Lahti, A.; Kankaanranta, H.; Moilanen, E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy, 2005, 4(4), 471-479.
223. Deng, Q.G.; She, H.; Cheng, J.H.; French, S.W.; Koop, D.R.; Xiong, S.; Tsukamoto, H. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology, 2005, 42(4), 905-914.
224. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κ B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κ B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm., 2007, 2007.
225. Wang, Y.; Ausman, L.M.; Russell, R.M.; Greenberg, A.S.; Wang, X-D. Increased Apoptosis in High-Fat Diet–Induced Nonalcoholic Steatohepatitis in Rats Is Associated with c-Jun NH2-Terminal Kinase Activation and Elevated Proapoptotic Bax. J. Nutr., 2008, 138(10), 1866-1871.
226. Castro, S.B.; Junior, C.O.; Alves, C.; Dias, A.T.; Alves, L.L.; Mazzoccoli, L.; Mesquita, F.P.; Figueiredo, N.S.; Juliano, M.A.; Castanon, M.C. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after Otetradecanoyl- genistein treatment. Int. Immunopharmacol., 2012, 12(2), 465-470.
227. McDowell, M.L.; Das, A.; Smith, J.A.; Varma, A.K.; Ray, S.K.; Banik, N.L. Neuroprotective effects of genistein in VSC4. 1 motoneurons exposed to activated microglial cytokines. Neurochem. Int., 2011, 59(2), 175-184.
228. Bitto, A.; Burnett, B.; Polito, F.; Levy, R.; Marini, H.; Di Stefano, V.; Irrera, N.; Armbruster, M.; Minutoli, L.; Altavilla, D. Genistein aglycone reverses glucocorticoid_induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br. J. Pharmacol., 2009, 156(8), 1287-1295.
229. Duan, W.; Kuo, I.C.; Selvarajan, S.; Chua, K.Y.; Bay, B.H.; Wong, W.S. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am. J. Respir. Crit. Care Med., 2003, 167(2), 185-192.
230. Ibrahim, A.S.; El-Shishtawy, M.M.; Pena Jr, A.; Liou, G.I. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol. Vis., 2010, 16, 2033.
231. Bitto, A.; Burnett, B.; Polito, F.; Marini, H.; Levy, R.; Armbruster, M.; Minutoli, L.; Di Stefano, V.; Irrera, N.; Antoci, S. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br. J. Pharmacol., 2008, 155(6), 896-905.
232. Albertazzi, P. Purified phytoestrogens in postmenopausal bone health: is there a role for genistein? Climacteric, 2002, 5(2), 190-196.
233. Crisafulli, A.; Marini, H.; Bitto, A.; Altavilla, D.; Squadrito, G.; Romeo, A.; Adamo, E.B.; Marini, R.; D'Anna, R.; Corrado, F.; and others. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause, 2004, 11(4), 400-404.
234. Marini, H.; Minutoli, L.; Polito, F.; Bitto A.; Altavilla, D.; Atteritano, M.; Gaudio, A.; Mazzaferro, S.; Frisina, A.; Frisina, N.; and others. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann. Intern. Med., 2007, 146(12), 839-847.
235. Reginster, J-Y.; Minne, H.; Sorensen, O.; Hooper, M.; Roux, C.; Brandi, M.; Lund, B.; Ethgen, D.; Pack, S.; Roumagnac, I. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporis Int., 2000, 11(1), 83-91.
236. Li, Y-Q.; Xing, X-H.; Wang, H.; Weng, X-L.; Yu, S-B.; Dong, G-Y. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. Acta Pharmacol. Sin., 2011, 33(1), 66-74.
237. Hirata, F.; Harada, T.; Corcoran, G.B.; Hirata, A. Dietary flavonoids bind to mono-ubiquitinated annexin A1 in nuclei, and inhibit chemical induced mutagenesis. Mutat. Res.-Fund. Mol. M., 2014, 759, 29-36.
238. Plewa, M.J.; Wagner, E.D.; Berhow, M.A.; Conway, A.; Rayburn, A.L.; Anderson, D. Antimutagenic activity of chemical fractions isolated from a commercial soybean processing by_product. Teratog., Carcinog. Mutagen., 1999, 19(2), 121-135.
239. Yang, Y.; Fix, D. Genetic analysis of the anti-mutagenic effect of genistein in Escherichia coli. Mutat. Res.-Fund. Mol. M., 2006, 600(1), 193-206.
240. Chan, H.Y.; Wang, H.; Leung, L.K. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7, 12-dimethylbenz[a] anthracene. Br. J. Nutr., 2003, 90(01), 87-92.
241. Wang, S-D.; Chen, B-C.; Kao, S-T.; Liu, C-J.; Yeh, C-C. Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement. Altern. Med., 2014, 14(1), 26.
242. Weisburger, J.H.; Dolan, L.; Pittman, B. Inhibition of PhIP mutagenicity by caffeine, lycopene, daidzein, and genistein. Mutat. Res.-Gen. Tox. En., 1998, 416(1), 125-128.
243. Kanazawa, T.; Osanai, T.; Zhang, X.S.; Uemura, T.; Yin, X.Z.; Onodera, K.; Oike, Y.; Ohkubo, K. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J. Nutr., 1995, 125(3 Suppl), 639s-646s.
244. Hoie, L.H.; Guldstrand, M.; Sjoholm, A.; Graubaum, H.J.; Gruenwald, J.; Zunft, H.J.; Lueder, W. Cholesterol-lowering effects of a new isolated soy protein with high levels of nondenaturated protein in hypercholesterolemic patients. Adv. Ther., 2007, 24(2), 439-447.
245. D'Anna, R.; Cannata M.L.; Atteritano M.; Cancellieri F.; Corrado F.; Baviera, G.; Triolo, O.; Antico, F.; Gaudio, A.; Frisina, N. and others. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause, 2007, 14(4), 648-655.
246. Sartippour, M.R.; Rao, J.Y.; Apple, S.; Wu, D.; Henning, S.; Wang, H.; Elashoff, R.; Rubio, R.; Heber, D.; Brooks, M.N. A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr. Cancer, 2004, 49(1), 59-65.
247. Squadrito, F.; Marini, H.; Bitto, A.; Altavilla, D.; Polito, F.; Adamo, E.B.; D'Anna, R.; Arcoraci, V.; Burnett, B.P.; Minutoli, L.; and others. Genistein in the metabolic syndrome: results of a randomized clinical trial. J. Clin. Endocrinol. Metab., 2013, 98(8), 3366-3374.
248. Irace, C.; Marini, H.; Bitto, A.; Altavilla, D.; Polito, F.; Adamo, E.B.; Arcoraci, V.; Minutoli, L.; Di Benedetto, A.; Di Vieste, G.; and others. Genistein and endothelial function in postmenopausal women with metabolic syndrome. Eur. J. Clin. Invest., 2013, 43(10), 1025-1031.
249. Leopold, A.S.; Erwin, M.; Oh, J.; Browning, B. Phytoestrogens: adverse effects on reproduction in California quail. Science, 1976, 191(4222), 98-100.
250. Berger, P.J.; Sanders, E.H.; Gardner, P.D.; Negus, N.C. Phenolic plant compounds functioning as reproductive inhibitors in Microtus montanus. Science, 1977, 195(4278), 575-577.
251. Setchell, K.D.; Gosselin, S.J.; Welsh, M.B.; Johnston, J.O.; Balistreri, W.F.; Kramer, L.W.; Dresser, B.L.; Tarr, M.J. Dietary estrogens--a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology, 1987, 93(2), 225-233.
252. Newbold, R.R.; Banks, E.P.; Bullock, B.; Jefferson, W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res., 2001, 61(11), 4325-4328.
253. Delclos, K.B.; Bucci, T.J.; Lomax, L.G.; Latendresse, J.R.; Warbritton, A.; Weis, C.C.; Newbold, R.R. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol., 2001, 15(6), 647-663.
254. Jefferson, W.N.; Couse, J.F.; Padilla-Banks, E.; Korach, K.S.; Newbold, R.R. Neonatal exposure to genistein induces estrogen receptor (ER) α expression and multioocyte follicles in the maturing mouse ovary: evidence for ERβ-mediated and nonestrogenic actions. Biol. Reprod., 2002, 67(4), 1285-1296.
255. Jefferson, W.N.; Padilla-Banks, E.; Newbold, R.R. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol. Reprod., 2005, 73(4), 798-806.
256. Jefferson, W.N.; Padilla_Banks, E.; Newbold, R.R. Disruption of the developing female reproductive system by phytoestrogens: genistein as an example. Mol. Nutr. Food Res., 2007, 51(7), 832-844.
257. Kouki, T.; Kishitake, M.; Okamoto, M.; Oosuka, I.; Takebe, M.; Yamanouchi, K. Effects of neonatal treatment with phytoestrogens, genistein and daidzein, on sex difference in female rat brain function: estrous cycle and lordosis. Horm. Behav., 2003, 44(2), 140-145.
258. Nagao, T.; Yoshimura, S.; Saito, Y.; Nakagomi, M.; Usumi, K.; Ono, H. Reproductive effects in male and female rats of neonatal exposure to genistein. Reprod. Toxicol., 2001, 15(4), 399-411.
259. Nikaido, Y.; Yoshizawa, K.; Danbara, N.; Tsujita-Kyutoku, M.; Yuri, T.; Uehara, N.; Tsubura, A. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod. Toxicol., 2004, 18(6), 803-811.
260. Whitten, P.L.; Lewis, C.; Russell, E.; Naftolin, F. Phytoestrogen influences on the development of behavior and gonadotropin function. Exp. Biol. Med., 1995, 208(1), 82-86.
261. Hilakivi-Clarke, L.; Onojafe, I.; Raygada, M.; Cho, E.; Skaar, T.; Russo, I.; Clarke, R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer, 1999, 80(11), 1682.
262. Faber, K.A.; Hughes Jr, C.L. Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats. Reprod. Toxicol., 1993, 7(1), 35-39.
263. Levy, J.R.; Faber, K.A.; Ayyash, L.; Hughes, C.L. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Exp. Biol. Med., 1995, 208(1), 60-66.
264. Program, N.T. Toxicology and carcinogenesis studies of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study). Natl. Toxicol. Program Tech. Rep. Ser., 2008, (545), 1.
265. Rietjens, I.M.; Sotoca, A.M.; Vervoort, J.; Louisse, J. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol. Nutr. Food Res., 2013, 57(1), 100-113.
266. Thigpen, J.E.; Haseman, J.K.; Saunders, H.E.; Setchell, K.D.; Grant, M.G.; Forsythe, D.B. Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice. Comp. Med., 2003, 53(6), 607-615.
267. Weber, K.S.; Setchell, K.D.; Stocco, D.M.; Lephart, E.D. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J. Endocrinol., 2001, 170(3), 591-599.
268. North, K.; Golding, J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJUI, 2000, 85(1), 107-113.
269. Duncan, L.; Robinson, G.; Ghilchik, M.; Reed, M. The effect of gross cystic disease fluid proteins on oestrogen synthesis in breast cancer cells. Endocr.-Relat. Cancer, 1994, 1(2), 27-35.
270. Maskarinec, G.; Nagata, C.; Shimizu, H.; Kashiki, Y. Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int. J. Cancer, 2002, 102(1), 29-33.
271. Goldman, L.R.; Newbold, R.; Swan, S.H. Exposure to soy-based formula in infancy. JAMA, 2001, 286(19), 2402-2403.
272. Strom, B.L.; Schinnar, R.; Ziegler, E.E.; Barnhart, K.T.; Sammel, M.D.; Macones, G.A.; Stallings, V.A.; Drulis, J.M.; Nelson, S.E.; Hanson, S.A. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA, 2001, 286(7), 807-814.
273. Charles, C.; Yuskavage, J.; Carlson, O.; John, M.; Tagalicud, A.S.; Maggio, M.; Muller, D.C.; Egan, J.; Basaria, S. Effects of highdose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause, 2009, 16(2), 395-400.